5.11.2017 | Ajankohtaista
Medical Manager – AbbVie; Helsinki, Finland
Job description
AbbVie on maailmanlaajuinen, tutkimuslähtöinen biolääkealan yhtiö, joka aloitti toimintansa vuonna 2013 eriydyttyään Abbottista. AbbViessä yhdistyvät bioteknologia-alan yrityksen fokus sekä pitkään toimineen johtavan lääkealan yrityksen asiantuntemus. Yhtiön missiona on kehittää ja markkinoida kehittyneitä hoitoja hankaliin ja vakaviin sairauksiin asiantuntemuksensa, sitoutuneen henkilöstönsä ja innovaatiokykynsä avulla. Vuonna 2017 AbbVien henkilöstöön kuuluu noin 29 000 työntekijää ja yhtiö markkinoi lääkkeitä yli 175 maassa.
Suomessa AbbVie Oy on yksi Suomen parhaista työpaikoista. Organisaatiomme työllistää noin 85 ammattilaista Suomessa. Terapia-alueisiimme kuuluvat immunologia, onkologia, virologia ja neurologia. Työskentelemme matriisitiimeissä, joissa eri alueiden asiantuntijat toimivat yhteisen tavoitteen eteen. Haluamme, että kulttuurimme ja työilmapiirimme tukee työn iloa ja onnistumista sekä työn ja vapaa-ajan yhteensovittamista. Lue lisää meistä: www.abbvie.fi.
Haemme nyt Lääketieteelliselle osastollemme
Medical Manageria
vastaamaan immunologian terapia-alueen lääketieteellisestä työstä ja johtamaan neljän hengen asiantuntijatiimiä. Tiimin tehtävänä on tuottaa ja jakaa lääketieteellistä tietoa sekä antaa tieteellistä tukea sekä ulkoisille että sisäisille asiakkaille. Vastaat terapia-alueen lääketieteellisestä strategiasta sekä toimenpiteistä. Huolehdit, että kaikessa toiminnassa noudatetaan lakeja ja säädöksiä sekä sovittuja linjauksia. Varmistat, että sinulla ja tiimiläisilläsi on alan tuoreimmat tiedot seuraamalla tieteellisiä julkaisuja sekä osallistumalla kongresseihin. Luot ja ylläpidät hyviä suhteita tärkeimpiin asiakkaisiin sekä alan vaikuttajiin. Työskentelet tiiviissä yhteistyössä lääketieteellisen osaston kollegojesi, myynti- ja markkinointiosaston, kliinisen tutkimusosaston sekä Market Accessin kanssa. Raportoit tehtävässäsi Medical Directorille.
Odotamme sinulta monipuolista kokemusta ja näyttöä lääkealalta sekä jatkuvasti muuttuvan lääkealan ympäristön tuntemusta. Lisäksi tehtävä edellyttää lääketieteellistä, luonnontieteellistä tai muuta soveltuvaa ylempää korkeakoulututkintoa sekä vahvaa tieteellistä orientaatiota. Tieteellinen jatkokoulutus on tehtävässä eduksi, samoin immunologian terapia-alueen tuntemus. Esimiestyön ohella haluat kehittyä edelleen myös terapia-alueesi tieteellisenä asiantuntijana. Sinulla on erinomaiset vuorovaikutus- ja ihmisten johtamisen taidot sekä vahvat valmiudet luoda verkostoja ja toimia eri sidosryhmien kanssa.
Kommunikoit sujuvasti kirjallisesti ja suullisesti sekä suomeksi että englanniksi. Olet kiinnostunut työskentelemään kaupallisessa ympäristössä ja vaikuttamaan potilaiden hoitoon yhteistyössä alan asiantuntijoiden kanssa.Tarjoamme ainutlaatuisen näköalapaikan terveydenhuoltosektorilla osana menestyvää ja kasvavaa kansainvälistä yritystä sekä ympärillesi osaavan ja dynaamisen työyhteisön. Haluamme auttaa henkilöstöämme kehittymään niin, että he voivat hyödyntää potentiaalinsa parhaalla mahdollisella tavalla.
Kiinnostuitko? Lisätietoja tehtävästä antaa Medical Director Anne Lehtonen 7.11. klo 9–11 ja 8.11. klo 15–17, puh. 040 902 2397. Muina aikoina voit olla yhteydessä MPS-konsultti Nina Kalajokeen puh. 020 746 9413. Täytä hakemuslomake palkkatoiveineen ja liitä mukaan hakemuksesi sekä CV:si osoitteessa uratori.mps.fi 12.11.2017 mennessä.
4.11.2017 | Ajankohtaista
The Tumor Genomics Research Group at the University of Helsinki’s Faculty of Medicine, is one of the largest biomedical research groups in Finland with a 30-member research team, including biologists, computer scientists and medical doctors. The group focuses on understanding the causes and mechanisms of tumorigenesis, particularly in uterine leiomyoma and colorectal cancer. Here, researchers are given the opportunity to work in an internationally acclaimed research environment and good working atmosphere. The group offers the availability of state-of-the-art facilities, equipment, and bioinformatic resources for high-throughput analyses. The work has led to publications in journals such as Science, Nature, and New England Journal of Medicine.The group is part of the Academy of Finland funded Center of Excellence in Tumor Genetics (CoETG) with a special focus on understanding the interplay between genetic and environmental signals leading to neoplasia.
We are currently seeking outstanding candidates for
POST-DOCTORAL RESEARCHER AND GRADUATE STUDENT POSITIONS
The open positions are in the fields of cancer genetics, systems biology and bioinformatics research. We are looking for ambitious post-doctoral researchers and doctoral students with strong enthusiasm towards science. We expect the successful candidate to be highly self-motivated and responsible with excellent team working, problem solving, and analytical skills. The successful candidate has a strong background in medicine, genetics, molecular biology or bioinformatics (computer science, statistics or machine learning). Basic understanding of cancer biology and genetics/genomics is also considered important.
Post-doctoral responsibilities
Post-docs are expected to be able to conduct their research projects independently and coordinate collaborative projects effectively. The work includes student supervision as well as helping with administrative tasks.
Graduate student responsibilities
Graduate students are expected to conduct their given research project ambitiously, effectively and with attention to detail. Graduate students are encouraged to do team-work within the group. All graduate students will have supervision from Prof. Aaltonen and a post-doc member of staff.
We offer an initial contract of employment for a minimum period of two years. The position is a full-time position preferably starting in spring 2018. A trial period of four months will be applied. Salary is based on the University’s salary scheme for teaching and research personnel, composed of both task specific and personal performance components. The group is situated in Biomedicum, at the Meilahti Campus in Helsinki, Finland.
Closing date for applications is 30.11.2017.
3.11.2017 | Ajankohtaista
The Translational Cancer Faster Forward Doctoral Programme
“Educate tomorrow’s cancer researchers in a broad set of scientific, transferable, and business skills to become entrepreneurs”
The CanFaster program is supported by the European Union’s Marie Skłodowska-Curie programme, which is part of the Horizon 2020 framework and based on the ”Mobility across boarders” philosophy.
The CanFaster programme aims to attract excellent international PhD candidates with an interest in applied medical research in oncology and entrepreneurship to Lund University, CREATE health and Medicon Village.The program build on collaboration between industry, healthcare and academia to strengthen and accelerate innovations and clinical implementation in oncology. The 16 PhD students will gain an understanding of unmet needs in the clinic and learn the mind-set of entrepreneurs in an upcoming PhD programme within cancer.
16 international PhD student positions within Cancer and Entrepreneurship:
• Secondments in the non-academic sector, such as clinic or industry.
• Courses in Entrepreneurship, Innovation processes, Clinical aspects of cancer
• Seminar series at Lund University Cancer Center and SMILE Business Incubator
• Generous full-time salary; positions start Q1-Q2 2018.
Application deadline 17th of November 2017.
2.11.2017 | Ajankohtaista
https://www.embl.de/jobs/searchjobs/index.php?ref=EBI_01079
2.11.2017 | Ajankohtaista
A postdoctoral position is available immediately in the Neurobiology of Motivated Behavior Laboratory (NMBL) at McLean Hospital, Harvard Medical School. This position is funded to investigate the regulation and role of reward circuit glutamatergic signaling in prescription opioid addiction using rodent (rat) models.
The ideal candidate will be a recent Ph.D. graduate with a relevant background in Neuroscience as well as rodent behavior and stereotaxic surgery. Candidates who have a successful track record of procuring fellowships will be given priority. The candidate will be proposed for academic appointment as a Research Fellow in the Department of Psychiatry at Harvard Medical School. The initial appointment will be for two years with the possibility of extension. Salary will be commensurate with qualifications, laboratory experience, and institutional guidelines.
Please send application materials (CV and a brief summary of career goals and objectives) and a list of three professional references to:
Elena Chartoff, Ph.D.
Assistant Professor of Psychiatry and Neuroscience
Harvard Medical School
Director, Neurobiology of Motivated Behavior Laboratory
McLean Hospital
115 Mill Street
Belmont, MA 02478
Review of applications will begin immediately and continue until the position is filled.
2.11.2017 | Ajankohtaista
Cowin lab postdoc ad
31.10.2017 | Ajankohtaista
The Institute for Molecular Medicine Finland (FIMM) is an international research institute focusing on human genomics and personalised medicine at the Helsinki Institute for Life Science of the University of Helsinki. FIMM is currently seeking a Post-doctoral Researcher in (Bio)-informatics/statistics for the Metabolomics Unit.
For further information please visit the website at
Closing date for applications is 12th November 2017.
30.10.2017 | Ajankohtaista
A postdoctoral position is available for a recent Ph.D. graduate to join the Contet laboratory at The Scripps Research Institute (La Jolla, CA) and study the neurobiological mechanisms of alcohol dependence. Our group investigates the proteins and neural circuits that are dysregulated by chronic alcohol exposure and their contribution to excessive drinking and other symptoms of alcohol dependence. We are looking for a candidate with strong expertise in molecular biology and histology techniques to analyze mouse brain samples for molecular quantification, cellular phenotyping and neurotracing. Additional experience with fiber photometry, microendoscopic imaging or adult brain cell sorting would be a major advantage. We are expecting a high degree of self-motivation, meticulousness, critical thinking, efficient communication and utmost research integrity.
The local scientific environment is optimal for young scientists to thrive. The Contet laboratory is part of TSRI Department of Neuroscience, Pearson Center for Alcoholism and Addiction Research, TSRI Alcohol Research Center, and TSRI Neuropsychopharmacology Training Program, which provide unique opportunities for multidisciplinary collaborations and outstanding resources for integrative training in the alcohol/drug addiction field.
This position offers standard NIH salary levels and competitive health insurance from TSRI. US citizenship or permanent residence is required for appointment to our NIH-funded Institutional Training Grant. Individuals from underrepresented racial and ethnic groups are encouraged to apply.
Interested candidates should send their application material (CV, cover letter and contact information for three references) to Dr. Candice Contet (contet@scripps.edu).
30.10.2017 | Ajankohtaista
A Postdoctoral Research Fellow position is available from Jan/Feb 2018 in the Tumor Microenvironment Lab at Institut Curie-Orsay (INSERM U1021, CNRS UMR3347, University
Paris-Sud), in Paris in the fields of glioblastoma and vascular biology.
The Institut Curie Research Center (https://institut-curie.org/profil/researchers) is a world-class multidisciplinary organization created in 1909 by Nobel Laureate Marie Curie bringing together France’s largest center in cancer research and a model hospital group dedicated entirely to the care of cancer patients. The institute is ranked in the top 1% by International Science Index. The scientists of Institut Curie laboratories have access to several state-of-art core facilities (such as functional genomics, proteomics, cellular and in vivo imaging, radiotherapy, bioinformatics, animal house and many others; https://institut-curie.org/page/platforms)
Glioblastoma is the most deadly type of human cancer. Recurrence is supposedly mostly caused by the regrowth of highly invasive cells spreading from the tumor bulk, which are not removed by resection. To develop therapeutic approaches, we need to better understand the underlying molecular mechanism of radioresistance and tumor spreading in glioblastoma.
I am looking for outstanding postdoctoral cell biologists with interest in, and ideally some experience of, brain tumors and radiobiology. I am also interested in applicants with experience in vascular biology or stem cells. This ATIP-Avenir funded project will give you the opportunity to extensively use in vivo experimental models and learn intravital microscopy. These studies will be supplemented with in vitro and ex vivomodels.
I am fresh of a 5-year postdoc experience in Harvard Medical School and, after publishing the results from my projects (in press), I am now opening a new laboratory in Institut Curie.
Consequently, there are several unique features of this postdoctoral opportunity:
1. Starting at ground zero with an enthusiastic Junior Group Leader and an experienced technician
in the outstanding environment of Institut Curie.
2. The goal of publishing good and comprehensive papers in high impact journals.
3. Basic science approaches to address clinically relevant issues in conjunction with clinician
scientists.
4. I have in depth appreciation of academic, clinics and industry.
5. You will be in an international-friendly laboratory (mainly English speaking).
30.10.2017 | Ajankohtaista
The Strategic Research Programme in Cancer (StratCan) at Karolinska Institutet (KI), together with the Karolinska University Hospital, are announcing up to three Clinical Researcher positions in Cancer Research. Priority will be given to the areas of molecular pathology and colorectal oncology for two of the positions, while the third position remains unspecified with regards to specialization.
Deadline for applications is November 20th at the latest.